Pharma Journalist -

Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. announced updated clinical data from the frontline arm of the Phase 1 KOMET-007 trial evaluating Ziftomenib in combination with intensive…
Read More...

Assertio Holdings, Inc. announced that its Board of Directors has approved a definitive agreement for Zydus Lifesciences Limited, through its subsidiary Zydus Worldwide DMCC, to acquire…
Read More...

Zai Lab Limited announced that the U.S. Food and Drug Administration has granted Fast Track Designation to Zocilurtatug pelitecan, also known as zoci and formerly identified as ZL-1310,…
Read More...

Isomorphic Labs announced that it has secured $2.1 billion in Series B financing to expand its artificial intelligence-powered drug discovery and development platform, marking one of…
Read More...

New Phase III clinical trial results presented at the European Congress of Endocrinology in Prague showed that Eneboparatide achieved significant improvements in calcium regulation and…
Read More...

The preliminary agenda for the 17th World ADC San Diego, taking place October 12–15, 2026, has been released, offering an exclusive first look at the scientific program for the world’s…
Read More...

GSK has announced an exclusive strategic collaboration with Sino Biopharmaceutical through its subsidiary Chia Tai Tianqing Pharmaceutical Group to accelerate the launch and…
Read More...

Bristol Myers Squibb announced that the European Commission has approved Sotyktu for the treatment of adults with active psoriatic arthritis (PsA) who have had an inadequate response or…
Read More...

The U.S. Food and Drug Administration has launched a new initiative aimed at accelerating the development of treatments for patients with unmet medical needs by exploring new uses for…
Read More...

Partner Therapeutics announced that the U.S. Food and Drug Administration has approved BIZENGRI for the treatment of adults with advanced, unresectable, or metastatic cholangiocarcinoma…
Read More...